The crystal structures of methoxmetamine hydrochloride and methoxetamine hydrochloride determined from laboratory X-ray powder diffraction data contained in the Powder Diffraction File ™
Source abstract
Abstract
Abstract The crystal structures of two arylcyclohexylamine derivatives – methoxmetamine·HCl (2-(3-methoxyphenyl)-2-(methylamino)cyclohexan-1-one hydrochloride, MMXE·HCl) and methoxetamine·HCl (2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one hydrochloride, MXE·HCl) – have been determined using laboratory X-ray powder diffraction data contained in the Powder Diffraction File ™ . MMXE·HCl and MXE·HCl exhibit anesthetic and sedative effects and have been illicitly used as recreational drugs due to their dissociative hallucinogenic and euphoriant effects. The structure determination of MMXE·HCl and MXE·HCl was carried out with DASH, and the Rietveld refinements were performed with TOPAS Academic in monoclinic unit cells. The parameters obtained for MMXE·HCl were a = 15.0429(5) Å, b = 14.0721(5) Å, c = 6.5716(2) Å, β = 90.9864(14)°, and V = 1,390.91(8) Å 3 , with Z = 4 and space group P 2 1 / n. The parameters obtained for MXE·HCl were a = 8.7772(5) Å, b = 9.9528(7) Å, c = 8.5841(6) Å, β = 100.276(3)°, and V = 737.86(8) Å 3 , with Z = 2 and space group P 2 1 . The structures were validated by dispersion-corrected DFT calculations. Hirshfeld surface analysis and fingerprint plots calculations are also reported.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: X-ray Diffraction in Crystallography · Crystallography and molecular interactions · Drug Solubulity and Delivery Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Universidad de los Andes
Canadian Light Source
University of Chemistry and Technology
Jan Evangelista Purkyně University in Ústí nad Labem
References (43)
Show source-provided references
1. 10.1002/anie.19951555110.1002/anie.199515551 ↗
2. 10.1017/S088571561400090610.1017/S0885715614000906 ↗
3. 10.1021/acs.joc.0c0109010.1021/acs.joc.0c01090 ↗
4. 10.1107/S002188988608945810.1107/S0021889886089458 ↗
5. 10.1103/PhysRevB.54.1116910.1103/PhysRevB.54.11169 ↗
6. 10.1107/S002188980604211710.1107/S0021889806042117 ↗
7. 10.1039/C8NJ03107J10.1039/C8NJ03107J ↗
8. 10.1107/S205252061402290210.1107/S2052520614022902 ↗
9. 10.1017/S088571562400015010.1017/S0885715624000150 ↗
10. 10.1107/S205252062300775810.1107/S2052520623007758 ↗
11. 10.1017/S088571561700086010.1017/S0885715617000860 ↗
12. Molecular and Crystal-structure of hydrochloride 2-(ortho-chlorphenyl)-2-(methylamino) cyclohexanone (ketamine)
13. 10.1021/acs.cgd.0c0028410.1021/acs.cgd.0c00284 ↗
14. 10.1107/S160053680802105310.1107/S1600536808021053 ↗
15. 10.1107/S010876730001217410.1107/S0108767300012174 ↗
16. 10.1017/S088571561900051410.1017/S0885715619000514 ↗
17. 10.1039/a700669a10.1039/a700669a ↗
18. 10.1007/s00894-012-1667-x10.1007/s00894-012-1667-x ↗
19. 10.1107/S002188986800508X10.1107/S002188986800508X ↗
20. 10.1107/S002188981202115210.1107/S0021889812021152 ↗
21. 10.1107/S160057672100291010.1107/S1600576721002910 ↗
22. 10.1107/S205698901901624410.1107/S2056989019016244 ↗
23. Babor, M. , Jurásek, B. , Kuchař, M. (2025). Personal communication.
24. 10.1107/S205252061600395410.1107/S2052520616003954 ↗
25. 10.1017/S088571562400040X10.1017/S088571562400040X ↗
26. 10.1017/S088571560001787510.1017/S0885715600017875 ↗
27. 10.1021/ar00172a00510.1021/ar00172a005 ↗
28. 10.1017/S088571561800053210.1017/S0885715618000532 ↗
29. 10.1021/ci049780b10.1021/ci049780b ↗
30. 10.1002/dta.162010.1002/dta.1620 ↗
31. 10.1021/ja00787a04310.1021/ja00787a043 ↗
32. 10.1107/S205698902101363310.1107/S2056989021013633 ↗
33. 10.1039/B818330A10.1039/B818330A ↗
34. 10.5281/zenodo.1057885510.5281/zenodo.10578855 ↗
35. Neumann, M. A. 2019. “GRACE (Version 2.6): Avant-Garde Materials Simulation SARL, France.” http://www.avmatsim.eu.
36. EMCDDA–Europol. 2014. “EMCDDA–Europol Joint Report on a New Psychoactive Substance: Methoxetamine (2-(3-Methoxyphenyl)-2-(Ethylamino)Cyclohexanone).” https://www.emcdda.europa.eu/publications/joint-report/methoxetamine_en. Accessed November 18, 2024.
37. 10.1515/ncrs-2021-005510.1515/ncrs-2021-0055 ↗
38. 10.1107/S160057671800018310.1107/S1600576718000183 ↗
39. 10.1021/jp050121r10.1021/jp050121r ↗
40. 10.1103/PhysRevLett.77.386510.1103/PhysRevLett.77.3865 ↗
41. 10.1007/s11419-015-0293-610.1007/s11419-015-0293-6 ↗
42. Diamond: Crystal and Molecular Structure Visualization
43. 10.1107/S002188987901178X10.1107/S002188987901178X ↗